Patent Assignment
Reel/Frame 018816/0737
Assignment of Assignor's Interest
Recorded: 2007-01-30
Received: 2007-01-30
Pages: 13
Assignor
AKZO NOBEL N.V.
Executed: 2007-01-12
Assignee
N.V. ORGANON
KLOOSTERSTRAAT 6, OSS, NLX, 5349 AB, NETHERLANDS
Covered Properties
(100)
(Indol-3-Yl) Heterocycle Derivatives as Agonists of the Cannabinoid CB1 Receptor
Application:
10/590,674 →
Indole Derivatives
Application:
11/506,579 →
Steroids Having a Mixed Androgenic and Progestagenic Profile
Application:
10/584,006 →
Tricyclic 1-[(Indol-3-Yl)Carbonyl]Piperazine Derivatives as Cannabinoid CB1 Receptor Agonists
Application:
10/583,013 →
Immediate-release pharmaceutical dosage form comprising polymorphous tibolone
Application:
10/503,356 →
Removal of lipopolysaccharides from protein-lipopolysaccharide complexes by non flammable solvents.
Application:
10/561,985 →
Tetrahydroquinoline Derivatives
Application:
10/540,336 →
Tetrahydorquinoline Derivatives and Their Use as Fsh Receptor Modulators
Application:
10/540,335 →
Chroman Derivatives as Estrogenic Compounds
Application:
11/328,760 →
Method for the Preparation of Enantiomerically Pure Mirtazapine
Application:
10/564,193 →
New Expression System from Rhodococcus
Application:
10/537,201 →
Drug Delivery System
Application:
10/558,040 →
2-(Benzimidazol-1-yl)-N-(4-phenylthiazol-2-yl) acetamide derivatives
Application:
60/734,446 →
2-(Benzimidazol-1-yl)-acetamide bisaryl derivatives
Application:
60/734,457 →
Use of Serotonergic Compound for a Method of Treatment of Hot Flushes in Post-Menopausal Women
Application:
11/231,653 →
Method for protein isolation in anoxic conditions
Application:
10/543,524 →
Self-administered contraceptive injection of oily solution
Application:
10/515,714 →
Method for Dissolution Testing of a Pharmaceutical Delivery Device
Application:
10/538,988 →
Novel Feeding Processes for Fermentation
Application:
11/123,715 →
Indoles Useful in the Treatment of Androgen-Receptor Related Diseases
Application:
10/534,945 →
Non-Steroidal Progesterone Receptor Modulators
Application:
10/510,275 →
Tetrahydrobenzfluorene Derivatives
Application:
10/499,956 →
1-[(Indol-3-Yl)Carbonyl]Piperazine Derivatives
Application:
10/518,279 →
Etonogestrel Esters
Application:
10/516,402 →
Use of new etonogestrel esters
Application:
10/517,362 →
Drug combination for the treatment of depression and related disorders comprising mirtazapine
Application:
10/996,213 →
Synergistic Combination of an Opioid Analgesic and a Nsaid
Application:
10/514,860 →
Apparatuses and processes for increasing protein PEGylation reaction yields
Application:
10/971,748 →
Testosterone Derivative
Application:
10/964,076 →
Controlled muscle relaxation
Application:
10/961,916 →
C-14 Oxidation of Morphine Derivatives
Application:
10/487,884 →
Methods for the Treatment of Major Depressive Disorder Using Glucocorticoid Receptor Antagonists
Application:
10/496,222 →
Substituted 10-Aryl-11H-Benzo[B]Fluourenes and 7-Aryl-5, 6-Dihydro-Benzo[a]Anthracenes for Selective Effects on Estrogen Receptors
Application:
10/505,631 →
1-Arylsulfonyl-3-Substituted Indole and Indoline Derivatives Useful in the Treatment of Central Nervous System Disorders
Application:
10/504,556 →
Identification of 3-Ketosteroid 9-Alfa-Hydroxylase Genes and Microorganisms Blocked in 3-Ketosteroid 9-Alfa-Hydroxylase Activity
Application:
10/504,034 →
Process for the preparation of 7alpha-methylsteroids
Application:
10/502,259 →
N-[(1-Dimethylaminocycloalkyl)Methyl]Benzamide Derivatives
Application:
10/484,410 →
Methods for removing suspended particles from soluble protein solutions
Application:
10/873,801 →
(Pyrido/Thieno) - [F] - Oxazepine-5-One Derivatives
Application:
10/480,569 →
Control of cyanate in aqueous urea solutions by non-1,2-ethylene diamine like compounds for the protection of protein/peptide carbamylation
Application:
10/836,879 →
Use of (11beta,17beta)-11-(1,3-benzodioxol-5-yl)-17-hydroxy-17-(1-propynyl)-estra-4,9-dien-3-one in the treatment of major depressive disorder
Application:
10/493,981 →
Vinyl Sulphone Modified Polymer
Application:
10/799,912 →
17ALPHA-Hydroxy-14BETA-Steroids with Hormonal Effect
Application:
10/489,456 →
Glycine-Substituted Thieno[2,3-D]Pyrimidines with Combined Lh and Fsh Agonistic Activity
Application:
10/488,483 →
THIENO[2,3-d]PYRIMIDINES WITH COMBINED LH AND FSH AGONISTIC ACTIVITY
Application:
10/488,482 →
Reagents for Protection of Peptide/Proteins Carbamylation in Urea Solutions Utilizing Non-Ethylene-Diamine Like Compounds
Application:
10/785,369 →
Technique for Output Power Dithering for Improved Transmitter Performance
Application:
10/779,606 →
Methods for improving the treatment of major depression by genotyping for the gene for apolipoproteine e4 and for improving the terapeutic response of humans having major depression and carrying the gene for apolipoprotein e4
Application:
10/467,768 →
Allelic variants of grp50
Application:
10/484,096 →
Tetrahydroquinoline Derivatives
Application:
10/482,707 →
Benzoxazepines Derivatives and Their Use as Ampa Receptor Stimulators
Application:
10/480,623 →
2-Alkylated-Cyclodextrin Derivatives: Reversal Agents for Drug-Induced Neuromuscular Block
Application:
10/468,072 →
Therapeutic compounds
Application:
10/718,398 →
Peptidylarginine Deiminase 6
Application:
10/476,899 →
Methods for removing suspended particles from soluble protein solutions
Application:
10/698,230 →
Methods for removing suspended particles from soluble protein solutions
Application:
10/698,238 →
Use of cortisol-sequestering agents for the treatment of hypercortisolaemia related disorders
Application:
10/415,867 →
Coactivation of Nuclear Receptors
Application:
10/362,463 →
Method and a System for Administerinng Muscle Relaxant to a Patient
Application:
10/468,312 →
Spiro(2H-1BENZOPYRAN-2,4'-Piperidine) Derivates as Glycine Transport Inhibitors
Application:
10/637,681 →
Novel testosterone ester formulation for human use
Application:
10/362,350 →
10-Aryl-11H-Benzo[B]Fluorene Derivatives and Analogs for Medicinal Use
Application:
10/362,555 →
Alanine 2, 6-Dialkoxyphenyl Ester Derivatives as Hypnotics
Application:
10/466,805 →
16ALPHA-Methyl or Ethyl Substituted Estrogens
Application:
10/343,293 →
Methods and compositions for inactivating viruses
Application:
10/602,129 →
6-Mercapto-Cyclodextrin Derivatives: Reversal Agents for Drug-Induced Neuromuscular Block
Application:
10/603,355 →
14 Beta, 16, 17-Methylene Steroids as Novel Androgens
Application:
10/450,278 →
Bicyclic Heteroaromatic Compounds Useful as Lh Agonists
Application:
10/411,960 →
Bicyclic Heteroaromatic Compounds
Application:
10/381,248 →
Use of Antibodies Against Specific Mhc-Peptide Complexes
Application:
10/344,872 →
16,17-Carbocyclic Condensed Steroid Compounds Having Selective Estrogenic Activity
Application:
10/297,706 →
Non-Steroidal, Tetracylic Compounds for Estrogen-Related Treatments
Application:
10/240,129 →
Full Length Human HCN1IH Channel Subunit and Variants
Application:
10/296,270 →
Synergistic Activation of Regulatory Elements by Rel Proteins and a Steroid Receptor
Application:
10/220,709 →
Increased Dynamic Binding Capacity in Ion Exchange Chromatography by Addition of Polyethylene Glycol
Application:
10/292,950 →
Novel Feeding Processes for Fermentation
Application:
10/292,064 →
Drug Combination for the Treatment of Depression and Related Disorders Comprising Mirtazapine
Application:
10/181,843 →
Use of Serotonergic Compound for a Method of Treatment of Hot Flushes in Post-Menopausal Women
Application:
10/256,474 →
Novel Androgens
Application:
10/148,820 →
Chroman Derivatives as Estrogenic Compounds
Application:
10/220,509 →
Antithrombotic Compound
Application:
10/148,868 →
Use of Chemical Chelators as Reversal Agents for Drug-Induced Neuromuscular Block
Application:
10/049,393 →
6-Mercapto-Cyclodextrin Derivatives:Reversal Agents for Drug-Induced Neuromuscular Block
Application:
10/148,307 →
Use of Mirtazapine for the Treatment of Sleep Disorders
Application:
10/203,232 →
Heterocyclic Derivatives and Their Use as Antithrombotic Agents
Application:
10/178,441 →
3-Methylene Steroid Derivatives
Application:
10/148,247 →
Non-Aromatic Estrogenic Steroids with a Hydrocarbon Substituent in Position 11
Application:
10/070,262 →
Spiro(2H-1-Benzopyran-2,4-Piperidine)Derivates as Glycine Transport Inhibitors
Application:
10/130,557 →
Formulation comprising testosteron undecanoate and castor oil
Application:
10/142,604 →
Methods and Compositions for Extracting Proteins from Cells
Application:
10/052,690 →
Serotonergic Compound for a Method of Treatment of Hot Flushes in Post-Menopausal Women
Application:
10/039,455 →
Bicyclic Heteroaromatic Compounds Useful as Lh Agonists
Application:
09/937,416 →
14-Beta,17-Alpha-Hydroxymethylandrostane Derivatives as Androgens
Application:
09/890,845 →
Orally Active Androgens
Application:
09/937,274 →
Folliculogenesis
Application:
09/856,995 →
22R-Hydroxycholesta-8,14-Diene Derivatives for the Inhibition of Meiosis
Application:
09/914,061 →
(Androst-5-En-17BETA-Yl)Alkyl Sulfoxides and Sulfones and Their Use for Control of Fertility
Application:
09/913,932 →
22S-Hydroxycholesta-8, 14-Diene Derivatives with Meiosis Regulating Activity
Application:
09/857,731 →
Estrogenic Estra-1,3,5(10)-Trienes with Differential Effects on the Alpha and Beta Estrogen Receptors, Having a Linear Hydrocarbon Chain of from 5-9 Carbon Atoms in Position 11
Application:
09/831,954 →
Compounds of Azetidine and Pyrroline
Application:
09/870,032 →